EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor

Kenneth C Childers iD, Nathan G Avery, Kevin A Estrada Alamo, Omar Davulcu iD, Rose Marie Haynes iD, Pete Lollar iD, Christopher B Doering iD, Carmen H Coxon iD, P Clint Spiegel

Blood Journal · 2023

DOI: 10.1182/blood.2023020181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Journal, 2023. Verfasst von Kenneth C Childers und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Western Washington University, Bellingham, WA. Hauptthemen laut MEDLINE: Hemophilia A, Hemostatics. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of pathogenic antibody inhibitors against coagulation factor VIII (FVIII) occurs in approximately 30% of congenital hemophilia A patients receiving FVIII replacement therapy as well as in all cases of acquired hemophilia A. KM33 is an anti-C1 domain antibody inhibitor previously isolated from a severe hemophilia A patient. In addition to potently blocking FVIII binding to von Willebrand factor and phospholipid surfaces, KM33 disrupts FVIII binding to lipoprotein receptor-related protein 1 (LRP1), which drives FVIII hepatic clearance and antigen presentation in dendritic cells. Here, we report on the structure of FVIII bound to NB33, a recombinant derivative of KM33, by single-particle cryo-electron microscopy. Structural analysis reveals the NB33 epitope localizes to FVIII residues R2090-S2094 and I2158-R2159 which constitute membrane-binding loops in the C1 domain. Further analysis reveals multiple FVIII lysine and arginine residues, previously shown to mediate binding to LRP1, dock onto an acidic cleft at the NB33 variable domain interface, thus blocking a putative LRP1 binding site. Together, these results demonstrate a novel mechanism of FVIII inhibition by a patient-derived antibody inhibitor and provide structural evidence toward engineering FVIII with reduced LRP1-mediated clearance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AHemostaticsHumansFactor VIIICryoelectron MicroscopyProtein Domainsvon Willebrand Factor

Substanzen

Factor VIIIvon Willebrand FactorHemostatics

Autor:innen und Institutionen

  • Chemistry Department, Western Washington University, Bellingham, WA.
  • Pacific Northwest Center for Cryo-EM, Oregon Health & Science University, Portland, OR.
  • Pacific Northwest National Laboratory, Environmental Molecular Sciences Laboratory, Richland, WA.
  • Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA.
  • Expression Therapeutics Inc, Tucker, GA.
  • National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, United Kingdom.

ORCID-Profile: Kenneth C Childers, Omar Davulcu, Rose Marie Haynes, Pete Lollar, Christopher B Doering, Carmen H Coxon

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Childers, K. C., Avery, N. G., Estrada Alamo, K. A., Davulcu, O., Haynes, R. M., Lollar, P., Doering, C. B., Coxon, C. H., & Spiegel, P. C. (2023). Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor. Blood Journal. https://doi.org/10.1182/blood.2023020181

Vancouver

Childers KC, Avery NG, Estrada Alamo KA, Davulcu O, Haynes RM, Lollar P, et al. Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor. Blood Journal. 2023. doi:10.1182/blood.2023020181

BibTeX
@article{Childers2023,
  author = {Childers, Kenneth C and Avery, Nathan G and Estrada Alamo, Kevin A and Davulcu, Omar and Haynes, Rose Marie and Lollar, Pete and Doering, Christopher B and Coxon, Carmen H and Spiegel, P Clint},
  title = {Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor},
  journal = {Blood Journal},
  year = {2023},
  doi = {10.1182/blood.2023020181}
}
Kostenlos starten →